Results 121 to 130 of about 536 (130)

Favorable Efficacy of Daclatasvir Plus Asunaprevir in Treatment of Elderly Japanese Patients Infected With HCV Genotype 1b Aged 70 and Older

Journal of Medical Virology, 2017
Norio Akuta, Tetsuya Hosaka, Hiromitsu Kumada   +2 more
exaly  

A Rugged and Accurate Liquid Chromatography–Tandem Mass Spectrometry Method for the Determination of Asunaprevir, an NS3 Protease Inhibitor, in Plasma

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences, 2013
Long Yuan, Mark Arnold, Hao Jiang
exaly  

Efficacy and Safety of Daclatasvir Plus Asunaprevir Therapy for Chronic Hepatitis C Patients With Renal Dysfunction

Journal of Medical Virology, 2017
Masataka Tsuge, Takashi Nakahara, Michio Imamura   +2 more
exaly  

Daclatasvir Plus Asunaprevir in Treatment-Naïve Patients With Hepatitis C Virus Genotype 1b Infection

World Journal of Gastroenterology, 2018
Wen Xie, Mingxiang Zhang, Yash Gandhi
exaly  

Asunaprevir and Daclatasvir in Hemodialysis Patients With Chronic Hepatitis C Virus Genotype 1b Infection

JGH Open, 2017
Iwata Ozaki, Taiga Otsuka, Yasushi IDE
exaly  

Case Report: Successful Retreatment of Hepatitis C Genotype 1b Infection With Sofosbuvir + Simeprevir in a Patient With Cirrhosis Who Had Prior Virologic Relapse After Treatment With Daclatasvir and Asunaprevir

Clinical Case Reports (discontinued), 2016
Navdeep Boparai
exaly  

Daclatasvir and Asunaprevir for Genotype 1b Chronic Hepatitis C Patients With Chronic Kidney Disease

Hepatology Research, 2017
Akihito Tsubota, Yasuhito Tanaka, Katsuhiko Iwakiri   +2 more
exaly  

A Phase 3, Open-Label Study of Daclatasvir Plus Asunaprevir in Asian Patients With Chronic Hepatitis C Virus Genotype 1b Infection Who Are Ineligible for or Intolerant to Interferon Alfa Therapies With or Without Ribavirin

Journal of Gastroenterology and Hepatology (Australia), 2016
Wen Xie, Mingxiang Zhang, Wan-Long Chuang   +2 more
exaly  

Asunaprevir/beclabuvir/daclatasvir

Reactions Weekly, 2018
openaire   +1 more source

Asunaprevir/daclatasvir/tacrolimus

Reactions Weekly, 2016
openaire   +1 more source